| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Executive VP, Global R&D
1 company
Fridriksdottir Hafrun is an Executive VP, Global R&D at TEVA PHARMACEUTICAL INDUSTRIES LTD. Recent SEC Form 4 filings include 0 buys and 12 sells.
Estimated insider holdings value: $50K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 17, 2022 | TEVA Teva Pharmaceutical Industries Ltd | Executive VP, Global R&D | Sell | 130,000 | $8.22 | $1,068,067.00 | -98.9% | +33.3% | -3.2% | |
| Mar 7, 2022 | TEVA Teva Pharmaceutical Industries Ltd | Executive VP, Global R&D | Sale+OE | 33,579 | $7.45 | $250,219.50 | -9.1% | +23.6% | +28.8% | |
| Feb 28, 2022 | TEVA Teva Pharmaceutical Industries Ltd | Executive VP, Global R&D | Sale+OE | 7,590 | $8.14 | $61,799.30 | -10.4% | +11.9% | +21.9% | |
| Feb 9, 2022 | TEVA Teva Pharmaceutical Industries Ltd | Executive VP, Global R&D | Sale+OE | 6,116 | $9.06 | $55,412.18 | -10.6% | -16.7% | +9.2% | |
| Aug 10, 2021 | TEVA Teva Pharmaceutical Industries Ltd | Executive VP, Global R&D | Sell | 50,860 | $9.95 | $506,021.40 | -55.1% | -7.7% | +10.9% | |
| May 11, 2021 | TEVA Teva Pharmaceutical Industries Ltd | Executive VP, Global R&D | Sale+OE | 19,066 | $10.22 | $194,829.73 | -17.1% | -2.0% | -28.0% | |
| Mar 4, 2021 | TEVA Teva Pharmaceutical Industries Ltd | Executive VP, Global R&D | Sale+OE | 9,515 | $10.57 | $100,536.44 | -11.5% | - | - | |
| Mar 2, 2021 | TEVA Teva Pharmaceutical Industries Ltd | Executive VP, Global R&D | Sell | 50,000 | $10.82 | $540,890.00 | -43.8% | - | - | |
| Mar 1, 2021 | TEVA Teva Pharmaceutical Industries Ltd | Executive VP, Global R&D | Sale+OE | 10,912 | $10.83 | $118,185.69 | -8.7% | - | - | |
| Feb 16, 2021 | TEVA Teva Pharmaceutical Industries Ltd | Executive VP, Global R&D | Sale+OE | 2,098 | $11.12 | $23,335.84 | -2.0% | - | - |